Tempus introduces fuses, a program designed to transform therapeutic research and build the largest diagnostic platform using its novel foundation model

Chicago--(business wire)--tempus ai, inc. (nasdaq: tem), a technology company leading the adoption of ai to advance precision medicine and patient care, today announced the launch of its fuses program. this initiative will harness tempus' proprietary dataset to generate valuable insights for both patient care and research, combining the power of its data and machine learning capabilities to develop an ai enabled-diagnostic platform offering physicians the largest suite of algorithmic tests desi.
TEM Ratings Summary
TEM Quant Ranking